Home > Press > Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO
Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO as of July, 16 2007. Dr. Williams' vast experience and skills will be valuable as Platypus transitions from a start-up to a growth-phase company. Prior to joining Platypus, Dr. Williams served as Senior Vice President and was responsible for product development at Asuragen. Before joining Asuragen, he was Vice President and General Manager of Ambion Diagnostics where he was responsible for the successful commercialization of several FDA-regulated diagnostic products. In addition, Dr. Williams spent over 10 years at Roche Diagnostics where he held several senior level positions, and he was a Vice President at Roche Applied Science during the launch of the LightCycler and many new PCR-based products for life science and diagnostic markets. As a precursor to his time at Roche Applied Science, Dr. Williams was Director of Operations at Roche Molecular Systems and was responsible for the production of all Roche PCR products. Dr. Williams began his career in the bio/pharmaceutical industry at Promega Corporation where he spent six years as Director of Operations. Dr. Williams received both his BS and PhD degrees from the University of Wisconsin-Madison.
Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO
Madison, WI | Posted on July 17th, 2007
About Platypus Technologies, LLC
Platypus Technologies, LLC develops, produces and markets nanotechnologies for the analytic and life sciences. The Company offers a variety of nanostructured surfaces for use in research and is also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions. This technology fuses advances in nanoscale science, materials science, and molecular biology to provide advanced tools for use in proteomics, cell studies, environmental monitoring and in vitro diagnostics. The Company has 23 employees and is located in the Fitchburg Technology Campus.
For more information, please click here
Dr. Minnie Gupta
Director of Marketing
Copyright © Platypus Technologies, LLC
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Silicon Valley-Based Foresight Valuation Launches STR-IPô, a New Initiative for Startups to Discover the Value of Their Intellectual Property December 18th, 2014
Iranian Scientists Use Nanotechnology to Increase Power, Energy of Supercapacitors December 18th, 2014
Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014
First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014
Switching to spintronics: Berkeley Lab reports on electric field switching of ferromagnetism at room temp December 17th, 2014
ORNL microscopy pencils patterns in polymers at the nanoscale December 17th, 2014
Unraveling the light of fireflies December 17th, 2014
DELMIC reports on applications of their SPARC technology at the Chalmers University of Technology in Gothenburg, Sweden December 16th, 2014
Nanomedicine expert joins Rice faculty: Gang Bao combines genetic, nano and imaging techniques to fight disease December 17th, 2014
Nexeon Attracts ex-Nokia Product Executive to its Board of Directors December 15th, 2014
Arrowhead Appoints Patrick O'Brien as General Counsel December 4th, 2014
Mining entrepreneur Julian Malnic Joins Deep Space Industriesí Board: Deep Space Industries welcomes a prolific mining entrepreneur and accomplished company builder, Julian Malnic, to its Board of Directors November 14th, 2014